27 January 2012
Detailed results from ALSYMPCA phase III study with Alpharadin to be presented at 2012 Genitourinary Cancers Symposium (Abstracts #8 and #9)17 January 2012
Jeffrey W. Albers appointed President of Algeta US05 January 2012
Algeta President & CEO Andrew Kay to present at the 30th Annual J.P. Morgan Healthcare Conference

